Sequential administration of dose-dense epirubicin/cyclophosphamide followed by docetaxel/capecitabine for patients with HER2-negative and locally advanced or node-positive breast cancer

1. Nieto, Y.
2. Aramendía, J.M.
3. Espinós, J.
4. De La Cruz, S.
5. Fernández-Hidalgo, O.
6. Santisteban, M.
7. Arbea, L.
8. Aristu, J.
9. Martínez-Monge, R.
10. Moreno, M.
11. Pina, L.
12. Sola, J.
13. Zornoza, G.
14. Regueira, F.M.